Autism services company Cortica raised $40 million in a Series D extension, bringing the total round to $115 million. The extension was entirely strategic, led by CVS Health Ventures, in conjunction with LRVHealth, Ascension Investment Management (a subsidiary of Ascension), and the University of Wisconsin Foundation.
Founded to fix the fragmented care journey families typically experience when seeking diagnoses and treatments, Cortica’s whole-child, whole-family, value-based care model for autism spans medical treatment, neurodiversity-affirming behavioral therapy, developmental therapy (encompassing speech, occupational, physical, and music therapies), and family support and counseling. Read more.
